CABA – cabaletta bio, inc. (US:NASDAQ)
Stock Stats
News
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth [Yahoo! Finance]
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Form 10-Q Cabaletta Bio, Inc. For: Mar 31
Form 8-K Cabaletta Bio, Inc. For: May 15
Form ARS Cabaletta Bio, Inc. For: Dec 31
Form DEFA14A Cabaletta Bio, Inc.
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.